Skip to content
10-Q/A

Quarterly Report

Intellicell Biosciences, Inc.

0001013762-14-001191

← back to feed
Filed
Oct 8, 2014 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 21, 2013 316.66M sh
Stockholders Equity Q3 2013 · Dec 31, 2012 −$4.13M
Current Liabilities Q3 2013 · Dec 31, 2012 $7.08M
Total Liabilities Q3 2013 · Dec 31, 2012 $8.07M
Current Assets Q3 2013 · Dec 31, 2012 $295.59K
Total Assets Q3 2013 · Dec 31, 2012 $3.94M
Eps Basic Q3 2013 · Sep 30, 2012 −$0.05
Eps Basic Q3 2013 · Sep 30, 2012 −$0.01
Cost Of Revenue Q3 2013 · Sep 30, 2012 $137.39K
Cost Of Revenue Q3 2013 · Sep 30, 2012 $314.64K